David Faleck
@DavidFaleckMD
Followers
424
Following
233
Media
14
Statuses
222
Gastroenterologist @sloan_kettering. Focused on IBD, dysplasia, cancer, checkpoint inhibitors, immune-related toxicities
New York, NY
Joined June 2018
RT @MSKCME: Novel therapies are revolutionizing the landscape of cancer treatment. Join us in two weeks for a critical forum to explore the….
0
7
0
Congrats to our star med student / soon to be IM resident @PatrickMagahis and our team @MSKCancerCenter on this important study of CDI rates and outcomes in >600 pts on cancer immunotherapy.
Happy to share our recent @JNCCN study on #Cdiff infection in patients on #immunotherapy p/w diarrhea:.👉Common (18%).👉⬆️G3-4 diarrhea but antibiotic tx alone sufficient for most.👉24% required steroids for concomitant immune-related enterocolitis (1/2).
0
2
9
RT @DavidFaleckMD: @MondayNightIBD @DCharabaty 55M w/ UC x30y. Prior 5-ASA, 6MP. On IFX 5 mg/kg q8w x5y. Mild UC sx before infusions. 🔦Last….
0
13
0
RT @MondayNightIBD: At the 🔀of oncology & IBD: Let’s talk #immunotherapy in pts w #IBD. 📌Convo @DavidFaleckMD April 28. (Check the🌟B2B🧵on I….
0
8
0
RT @MondayNightIBD: At the 🔀of oncology & IBD: Let’s talk immunotherapy-induced enterocolitis (ICI/IMC). 📌#Back2Basics April14.📌Convo @Davi….
0
15
0
RT @Shang_Joa: Does the gut #microbiome predispose patients to immunotherapy-related colitis? Our study in @JExpMed explores the #microbiot….
0
7
0
RT @RockUPress: In @JExpMed, @Shang_Joa, @DavidFaleckMD, @jeremiahfaith1 et al. report that pretreatment gut #microbiomes of #immunotherapy….
0
4
0
RT @jitcancer: Here’s a closer look at recent #JITC article “Open-capsule budesonide for the treatment of immune-related enteritis from che….
0
2
0
Happy to share our experience using open capsule budesonide for successful treatment of immune-related enteritis. Grateful for my fantastic team @MSKCancerCenter who help treat these pts and made this study possible and ⭐️ med student @PatrickMagahis for putting this together.
New #JITC article: Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors @PatrickMagahis @DavidFaleckMD
2
2
12
RT @DrChoueiri: Thank you Dr Neil Shah @MSKCancerCenter for the keynote invite to the #MSKOTMCME —impressive multidisciplinary science-driv….
0
9
0
RT @MSKCME: Join us June 20 for the Oncologic Toxicity Management Symposium #MSKOTMCME. Expert faculty will present a cutting-edge, multidi….
0
5
0
Outstanding work @TanishaKalra14 expanding our knowledge of #immunotherapycolitis, in particular the underappreciated long duration of symptoms (>12 weeks) in many of our patients @MSKCancerCenter . Keep up the good work!.
Reflecting on #DDW2024 which was such a great mix of learning, meeting old friends and making new ones!. Thankful for the opportunity to present our study. Always grateful to @DavidFaleckMD for making me a part of it and guiding me through the process!.#GITwitter #MedTwitter
0
0
2
RT @jitcancer: New #JITC article: Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter….
0
8
0
Excited to share our study on the dysbiosis associated with #checkpointcolitis and ability to treat with #FMT. Fantastic collaboration with @ArielleElkrief and @tsonipeled who led the microbiome work. More to come in this space. @MSKCancerCenter.
0
0
9
Very grateful for my phenomenal and incredibly dedicated #colitis team @MSKCancerCenter and honored to receive the Dept of Medicine team-based award for "Excellence in Outpatient Care Collaboration". Truly takes a team to manage these complex patients. #IBD #irColitis
3
0
24
Thank you @jitcancer for highlighting our work and my excitement about all things GI + microbiome + cancer + immunotherapy! Grateful for fantastic collaborators @MSKCancerCenter including @MLaszkowskaMD @SteveMaronMD @YJanjigianMD and many others.
Meet the Author: Dr. David Faleck (@DavidFaleckMD), 5th year faculty (#ECR) from @MSKCancerCenter, is co-senior author of “Impact of Helicobacter Pylori Infection Status on Outcomes among Patients with Advanced Gastric Cancer Treated w/Immune Checkpoint Inhibitors,” in #JITC! 1/7
2
2
22
RT @jitcancer: Let’s look closer at “Impact of Helicobacter Pylori Infection Status on Outcomes among Patients with Advanced Gastric Cancer….
0
4
0
RT @MLaszkowskaMD: Excited to share our latest work in @jitcancer! @DavidFaleckMD @SteveMaronMD @CowzerDarren @YJanjigianMD @MSKCancerCente….
0
4
0